Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.

Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.

Item
http://www.wikidata.org/entity/Q38905765
Combined photothermal and photodynamic therapy by hyaluronic acid-decorated polypyrrole nanoparticles.Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy.Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model.Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy.Targeted and controlled drug delivery system loading artersunate for effective chemotherapy on CD44 overexpressing cancer cells.Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcomaHighly Stable PEGylated Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for the Effective Delivery of Docetaxel in Prostate Cancers.Combination of Oxaliplatin and Vit.E-TPGS in Lipid Nanosystem for Enhanced Therapeutic Efficacy in Colon Cancers.Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.Bioflavonoid Fisetin Loaded α-Tocopherol-Poly(lactic acid)-Based Polymeric Micelles for Enhanced Anticancer Efficacy in Breast Cancers.Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration.Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis.
P2860

Engineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecan.

Item
http://www.wikidata.org/entity/Q38905765
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Engineering of a lipid-polymer ...... of doxorubicin and irinotecan.
@en
type
label
Engineering of a lipid-polymer ...... of doxorubicin and irinotecan.
@en
prefLabel
Engineering of a lipid-polymer ...... of doxorubicin and irinotecan.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Engineering of a lipid-polymer ...... of doxorubicin and irinotecan.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698